- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 221/14 - Aza-phénalènes, p. ex. naphtalimide-1, 8
Détention brevets de la classe C07D 221/14
Brevets de cette classe: 170
Historique des publications depuis 10 ans
|
8
|
6
|
8
|
15
|
8
|
10
|
7
|
13
|
13
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Jawaharlal Nehru Centre for Advanced Scientific Research | 85 |
7 |
| San-Apro Limited | 78 |
7 |
| LG Chem, Ltd. | 17926 |
5 |
| Adeka Corporation | 1376 |
5 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 120 |
5 |
| Xiangbei Welman Pharmaceutical Co., Ltd. | 35 |
5 |
| Heraeus Epurio LLC | 11 |
5 |
| Guangzhou Xin-chuangyi Biopharmaceutical Co., Ltd | 26 |
5 |
| Sony Corporation | 30236 |
4 |
| Dalian Institute of Chemical Physics, Chinese Academy of Sciences | 701 |
4 |
| Nanjing Kangfushun Pharmaceutical Co., Ltd. | 22 |
4 |
| Guangzhou Century Clinical Research Co., Ltd | 23 |
4 |
| Merck Patent GmbH | 5725 |
3 |
| Alumend, LLC | 20 |
3 |
| Changzhou Tronly Advanced Electronic Materials Co., Ltd. | 87 |
3 |
| Council of Scientific & Industrial Research | 1442 |
3 |
| Heraeus Precious Metals North America Daychem LLC | 4 |
3 |
| Changzhou Tronly Opto-Electronic Materials Co., Ltd. | 13 |
3 |
| Guangzhou Xin Chuang Yi New Drug R&D Co.,Ltd | 7 |
3 |
| BASF SE | 21313 |
2 |
| Autres propriétaires | 87 |